Cargando…

Detection of Epithelial-Mesenchymal Transition Markers in High Grade Bladder Cancer and Special Variants of Urothelial Carcinoma

Transitional cell carcinoma is considered the most predominant type of bladder cancer. Bladder can cer can also be found as squamous cell carcinoma that accounts for 5% of the total bladder cancer due to its etiology. The biomarkers associated with grade, prognosis, and stage of the disease are not...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khalil, Heba, Hammam, Olfat Ali, Kamel, Amira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587820/ https://www.ncbi.nlm.nih.gov/pubmed/35763651 http://dx.doi.org/10.31557/APJCP.2022.23.6.2079

Ejemplares similares

Expression of epithelial-Mesenchymal transition related markers in Plasmacytoid Urothelial carcinoma of the urinary bladder
por: Nomura, Shunichiro, et al.
Publicado: (2020)

The Bladder Microbiome Is Associated with Epithelial–Mesenchymal Transition in Muscle Invasive Urothelial Bladder Carcinoma
por: Li, Wei Tse, et al.
Publicado: (2021)

Survival and Enrichment Analysis of Epithelial–Mesenchymal Transition Genes in Bladder Urothelial Carcinoma
por: Ali, Waleed, et al.
Publicado: (2023)

FUT7 Promotes the Epithelial–Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma
por: Liu, Mulin, et al.
Publicado: (2021)

Tissue Profile of CDK4 and STAT3 as Possible Innovative Therapeutic Targets in Urinary Bladder Cancer
por: Aboushousha, Tarek, et al.
Publicado: (2020)

Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes
por: Franzen, C A, et al.
Publicado: (2015)

Diagnostic roles of proliferative markers in pathological Grade of T1 Urothelial Bladder Cancer
por: Yang, Jianping, et al.
Publicado: (2021)

High-Grade Urothelial Carcinoma of Bladder Transforming to Micropapillary Variant on Follow-Up
por: Kumari, Nitu, et al.
Publicado: (2017)

Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis
por: Hammam, Olfat, et al.
Publicado: (2017)

Investigating the Impact of Optimized Trans-Cinnamic Acid-Loaded PLGA Nanoparticles on Epithelial to Mesenchymal Transition in Breast Cancer
por: Badawi, Noha M, et al.
Publicado: (2022)

The clinical significance of HER2 protein amplification/expression in urinary bladder lesion
por: Hammam, Olfat, et al.
Publicado: (2015)

An experimental model of the epithelial to mesenchymal transition and pro-fibrogenesis in urothelial cells related to bladder pain syndrome/interstitial cystitis
por: Jin, Xing-Wei, et al.
Publicado: (2021)

Colonic Stem Cells Expression of Lgr5 and CD133 Proteins as Predictive Markers in Colorectal Cancer among Egyptian Patients
por: Rosiq, Saed, et al.
Publicado: (2018)

The study of miRNA-200c expression and epithelial-to-mesenchymal transition-related transcription factors in the primary bladder urothelial carcinoma
por: Narwal, Anubhav, et al.
Publicado: (2023)

Epigenetic Regulation of Elf5 Is Associated with Epithelial-Mesenchymal Transition in Urothelial Cancer
por: Wu, Bo, et al.
Publicado: (2015)

Upregulation of Twist2 in Non-Muscle Invasive Urothelial Carcinoma of the Bladder Correlate with Response to Treatment and Progression
por: Wishahi, Mohamed, et al.
Publicado: (2018)

The Role of Histone Variants in the Epithelial-To-Mesenchymal Transition
por: Lone, Imtiaz Nisar, et al.
Publicado: (2020)

Prognostic Role of Epithelial-Mesenchymal Transition Markers “E-Cadherin, β-Catenin, ZEB1, ZEB2 and p63” in Bladder Carcinoma
por: Moussa, Rabab Ahmed, et al.
Publicado: (2019)

Nested variant of urothelial carcinoma of the urinary bladder
por: Terada, Tadashi
Publicado: (2011)

The expression of p63 in bladder cancer vs. chronic bilharzial bladder
por: Mursi, Khaled, et al.
Publicado: (2013)

Epigenetic Mechanisms Influencing Epithelial to Mesenchymal Transition in Bladder Cancer
por: Monteiro-Reis, Sara, et al.
Publicado: (2019)

Epithelial-to-Mesenchymal Transition Mediates Resistance to Maintenance Therapy with Vinflunine in Advanced Urothelial Cell Carcinoma
por: Font, Albert, et al.
Publicado: (2021)

Co-Expression of Stem Cell and Epithelial Mesenchymal Transition Markers in Circulating Tumor Cells of Bladder Cancer Patients
por: Zhang, Ruiyun, et al.
Publicado: (2020)

Transcriptomic analysis of micropapillary high grade T1 urothelial bladder cancer
por: Bowden, Michaela, et al.
Publicado: (2020)

Grading Systems for Canine Urothelial Carcinoma of the Bladder: A Comparative Overview
por: Brambilla, Eleonora, et al.
Publicado: (2022)

Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
por: Martins-Lima, Cláudia, et al.
Publicado: (2023)

Expression of the FGFR2 mesenchymal splicing variant in epithelial cells drives epithelial-mesenchymal transition
por: Ranieri, Danilo, et al.
Publicado: (2015)

Nuclear Localization of COX-2 in relation to the Expression of Stemness Markers in Urinary Bladder Cancer
por: Thanan, Raynoo, et al.
Publicado: (2012)

Tumor stemness score to estimate epithelial-to-mesenchymal transition (EMT) and cancer stem cells (CSCs) characterization and to predict the prognosis and immunotherapy response in bladder urothelial carcinoma
por: Zhang, Yanlong, et al.
Publicado: (2023)

Oncological Outcomes of Non-Urothelial Bladder Cancers in a Specialized Cancer Hospital of a Developing Country
por: Adnan, Siddique, et al.
Publicado: (2020)

Molecular Detection of Genetic Susceptibility to Bladder Cancer in Egyptian Patients
por: Mamdouh, Samah, et al.
Publicado: (2022)

Classification of Circulating Tumor Cells by Epithelial-Mesenchymal Transition Markers
por: Wu, Shiyang, et al.
Publicado: (2015)

Analysis of epithelial–mesenchymal transition markers in psoriatic epidermal keratinocytes
por: Man, Xiao-Yong, et al.
Publicado: (2015)

Evaluation of Epithelial–Mesenchymal Transition Markers in Autoimmune Thyroid Diseases
por: Sacristán-Gómez, Pablo, et al.
Publicado: (2023)

Downregulation of feline sarcoma-related protein inhibits cell migration, invasion and epithelial-mesenchymal transition via the ERK/AP-1 pathway in bladder urothelial cell carcinoma
por: Hu, Xudong, et al.
Publicado: (2017)

Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence
por: Mucciardi, Giuseppe, et al.
Publicado: (2014)

Prognostic Implications of Deep Muscle Invasion and High Grade for Bladder Urothelial Carcinoma
por: Hashmi, Atif A, et al.
Publicado: (2020)

Survivin and Her2 Expressions in Different Grades of Urothelial Neoplasms of Urinary Bladder
por: Moradi Tabriz, Hedieh, et al.
Publicado: (2021)

Role of the Epithelial-Mesenchymal Transition in Bladder Cancer: From Prognosis to Therapeutic Target
por: Yun, Seok Joong, et al.
Publicado: (2013)

The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression
por: Huang, Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vlvilre4codjr2lm7j1a9tui8a